ClinicalTrials.Veeva

Menu

NeuroTrainer Cognitive Training For Academic Focus

N

NeuroTrainer

Status

Not yet enrolling

Conditions

ADHD, Predominantly Hyperactive - Impulsive
ADHD - Combined Type
ADHD Predominantly Inattentive Type

Treatments

Behavioral: NeuroTrainer

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06512974
1R43MH135599-01A1

Details and patient eligibility

About

This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.

Full description

The goal of this clinical trial is to test the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control function in students with and without attention-related difficulties. The main questions it aims to answer are (1) does NeuroTrainer improve attentional and executive control function, (2) does NeuroTrainer engage the target of ADHD inattention symptoms by identifying the target and demonstrating proximal changes in it, and (3) does NeuroTrainer demonstrate transfer of skill with improvement in academic behaviors. Researchers will compare students who use NeuroTrainer to a control condition to see if the NeuroTrainer intervention produces significant improvements.

Participants in the intervention group will engage in virtual reality (VR) sessions which include physical activity and cognitive training. Cognitive training will maximize time at performance thresholds and optimize for variability in task dynamics and demands.

Enrollment

155 estimated patients

Sex

All

Ages

11 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe
  • Estimated IQ of 80 or greater
  • Between 11-17 years of age

Exclusion criteria

  • Presence of suicidality
  • Presence of psychotic disorders
  • Visual or hearing impairment
  • Presence of severe depression

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

155 participants in 2 patient groups

NeuroTrainer Intervention
Experimental group
Description:
The NeuroTrainer intervention involves using a VR-based cognitive training program designed to improve attention and executive function in students with ADHD. Participants will engage in 30-minute sessions, approximately three times a week for 12 weeks, performing game-like tasks that integrate physical activity and adapt to their performance level.
Treatment:
Behavioral: NeuroTrainer
Control Condition
No Intervention group
Description:
The control condition involves students receiving standard educational interventions without the use of NeuroTrainer. These activities include regular classroom instruction and typical academic tasks designed to support learning, without the additional cognitive training provided by the VR program.

Trial contacts and locations

0

Loading...

Central trial contact

Jeff Nyquist, Ph.D.; Julie Schweitzer, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems